Skip to content

The Effect of granulocyte colony-stimulating factor and erythropoietin on survival in patients with Acute-on-Chronic Liver Failure.

The Effect of granulocyte colony-stimulating factor and erythropoietin on survival in patients with Acute-on-Chronic Liver Failure

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2018/015
Enrollment
Unknown
Registered
2018-05-21
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-on-Chronic Liver Failure.

Interventions

Study setting: The patient with Acute-on-Chronic Liver Failure will be admitted into the Department of Hepatology at Bangabandhu Sheikh Mujib Medical University, Dhaka. Patients will be allocated int

Sponsors

Dr. Md. Nazmul Haque
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age:>18 years • Sex: both sexes • Bilirubin > 5 mg/dl • Coagulopathy (international normalized ratio > 1.5) • Complicated by clinical ascites and/or encephalopathy within 4 weeks • Patient with previously diagnosed or undiagnosed chronic liver disease • Acute insult caused by reactivation of HBV, HBV Flare, HEV,HAV or any aetiology

Exclusion criteria

Exclusion criteria: • Age <18 years • Decompensated Cirrhosis • Coexistent hepatocellular carcinoma (HCC) • Patients on immune-modulator or cytotoxic/immunosuppressive therapy • Co morbidity like heart failure, any malignancy and uncontrolled diabetic patients . • Any previous known hypersensitivity to G-CSF and EPO • Patients unwilling to take part in the study

Design outcomes

Primary

MeasureTime frame
Change in MELD score (Model for end stage liver disease) [At baseline and 90 days ] Change in CTP (Child-Turcotte-Pugh) score [ At baseline and 90 days] Survival [ At 90 days]

Secondary

MeasureTime frame
None [None]

Countries

Bangladesh

Contacts

Public ContactDr. Md. Nazmul Haque

MD Student

dr.nazmulhaquermc@gmail.com

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026